David M. Spencer, Chief Scientific Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 5,000 shares at $22.95 ($115K) on 2015-12-01, disclosed to the SEC on 2015-12-03.
Scheduled sale ($115k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BLCM | SELL | 2017-07-12 | $231K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $139K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $100K | — | Filing → |